Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

PROMOTION
Take 15% off!
Human High Sensitivity IL-6 ELISA Assay
for serum, plasma, and cell culture

Featured Products & Promotions

Latest News
  • Measuring cell metabolic activity in human breast cancer cells EZ4U - MTT Assay
    Measuring cell metabolic activity with EZ4U - MTT assay
    7 January, 2025
    Our EZ4U (Easy for You) cell proliferation and cytotoxicity MTT assay was applied in a recent study exploring the role of pertuzumab, a monoclonal antibody that targets HER2, in disrupting the transactivation between the epidermal growth factor receptor (EGFR) and HER2 in HER2-positive cancers. The research focuses on understanding how this disruption could predict therapeutic [...]
  • Biomarker Testing Service from Biomedica
    Biomarker Testing Service from Biomedica
    17 December, 2024
    for  ELISA and Luminex Assays and microRNA Analysis With more than 30 years of expertise in the development and manufacturing of ELISA assay kits, Biomedica offers analytical testing services tailored for universities, clinical centers, as well as pharmaceutical and biotechnology industries. Our comprehensive range of analytical solutions ensures that we can provide exceptional service for your [...]
  • C4d and graft loss in KTR with IgAN
    C4d and graft loss in KTR with IgAN
    10 December, 2024
    C4d and graft loss in KTR with IgAN (abbrev. KTR: kidney transplant recipients, IgAN: IgA nephropathy) C4d analysis has become an important diagnostic tool used in the evaluation of kidney transplant recipients (1). C4d is a fragment of the complement component C4 that is produced during the activation of the complement system. In the context [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events